Search research articles
联系我们
Search research articles
Search
相关实验视频
对抗高血压药物的警告?
S E Kjeldsen
Lancet (London, England)
|
October 13, 2001
中文
概括
No abstract available in
PubMed
.
相关概念视频
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
Same author
Same journal
Same Topic
排序
Same author
Lowering Albuminuria-Does It Lower the Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.
Journal of the American Society of Nephrology : JASN
·
2023
Same author
Reducing Microalbuminuria-Does It Lower Cardiovascular Risk?: Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 45: 198-202, 2005.
Journal of the American Society of Nephrology : JASN
·
2023
Same author
Fixed-dose combination of nifedipine gastrointestinal therapeutic system and candesartan cilexetil in patients with moderate-to-severe essential hypertension: an open-label, long-term safety and efficacy study.
Journal of clinical pharmacy and therapeutics
·
2016
Same author
Blood pressure-lowering effects of nifedipine/candesartan combinations in high-risk individuals: subgroup analysis of the DISTINCT randomised trial.
Journal of human hypertension
·
2016
Same author
Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15,990 patients.
Journal of human hypertension
·
2014
Same author
Blood pressure changes after renal denervation at 10 European expert centers.
Journal of human hypertension
·
2013
查看更多